Celia Jenkinson
About Celia Jenkinson
Celia Jenkinson is a Principal Scientist and Director at Travere Therapeutics, with extensive experience in drug discovery and development. She has held significant roles at various pharmaceutical companies, including Janssen, GlaxoSmithKline, and Pfizer, and has a strong academic background with a PhD in Molecular Pharmacology.
Work at Travere Therapeutics
Celia Jenkinson has been serving as Principal Scientist and Director at Travere Therapeutics since 2017. In this role, she leads drug discovery projects from inception to clinical stages. Her responsibilities include establishing project strategy, budget, and resource needs for drug development projects. Jenkinson's work at Travere Therapeutics emphasizes her expertise in preclinical pharmacology and her ability to independently evaluate and progress new drug ideas through both internal and external partnerships.
Previous Experience in Pharmaceutical Companies
Prior to her current role, Celia Jenkinson held several significant positions in the pharmaceutical industry. She worked as a Scientific Director at Janssen, Pharmaceutical Companies of Johnson and Johnson from 2007 to 2013 in San Diego. Before that, she was a Group Manager at GlaxoSmithKline from 2001 to 2006 in RTP, North Carolina. Additionally, she served as a Senior Principal Scientist at Pfizer for 11 months in 2006 to 2007 in San Diego and as a Consultant at Caldan Therapeutics from 2016 to 2017 in the United Kingdom.
Education and Expertise
Celia Jenkinson holds a PhD in Molecular Pharmacology from The University of Glasgow, where she studied from 1990 to 1993. She also earned a BSc in Biochemistry from the University of Bristol from 1987 to 1990. Furthermore, she participated in the Start-Up Leadership Fellow program, focusing on Entrepreneurship from 2013 to 2014. Her educational background supports her specialization in GPCR-related therapies, particularly in the areas of Type 2 diabetes, obesity, and kidney disease.
Research and Contributions
Celia Jenkinson has a notable track record of publications, patents, and conference presentations, demonstrating her recognition in the scientific community. Her expertise in preclinical pharmacology and drug discovery has contributed to advancements in the field. She is skilled in establishing project strategies and managing resources for drug development projects, showcasing her leadership in advancing new therapeutic ideas.
Post-Doctoral Experience
Celia Jenkinson completed her post-doctoral fellowship at UCSD from 1994 to 1997 in San Diego. This experience provided her with foundational skills and knowledge in pharmacology, which she has built upon throughout her career in the pharmaceutical industry. Her post-doctoral training has been instrumental in shaping her approach to drug discovery and development.